Bellerophon Therapeutics在盘前股价暴跌39%,因公司将被纳斯达克摘牌。查看全文
临床治疗药物公司Bellerophon(BLPH.O)盘初跳涨18%,触及熔断。 网页链接
$柏勒罗丰治疗(BLPH)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2019-01-29 AccNo: 0001718111-19-000002 Size: 62 KB 网页链接
$柏勒罗丰治疗(BLPH)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2019-01-29 AccNo: 0001718111-19-000002 Size: 62 KB 网页链接
$柏勒罗丰治疗(BLPH)$ 内部交易: 2019-01-25,Director,Amin Naseem ,买入,571429普通股, $0.70
$柏勒罗丰治疗(BLPH)$ 内部交易: 2019-01-25,Director,Peacock Jonathan M ,买入,714286普通股, $0.70
$柏勒罗丰治疗(BLPH)$ 内部交易: 2019-01-25,Director,Wang Theodore T ,买入,450000普通股, $0.70
$柏勒罗丰治疗(BLPH)$ 8-K - Current report Filed: 2019-01-23 AccNo: 0001600132-19-000031 Size: 468 KBItem 1.01: Entry into a Material Definitive AgreementItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$柏勒罗丰治疗(BLPH)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2019-01-23 AccNo: 0001600132-19-000032 Size: 720 KB 网页链接
$柏勒罗丰治疗(BLPH)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2019-01-23 AccNo: 0001600132-19-000024 Size: 714 KB 网页链接
$柏勒罗丰治疗(BLPH)$ 8-K - Current report Filed: 2019-01-07 AccNo: 0001600132-19-000021 Size: 4 MBItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接
$柏勒罗丰治疗(BLPH)$ 8-K - Current report Filed: 2019-01-07 AccNo: 0001600132-19-000020 Size: 90 KBItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接